2005
DOI: 10.1177/107327480501200102
|View full text |Cite
|
Sign up to set email alerts
|

Diagnosis, Classification, and Management of Soft Tissue Sarcomas

Abstract: Competent imaging, predictive immunological and genetic studies, improved surgery, and newer methods of adjunctive and neoadjunctive treatment should result in improvements in outcomes for patients with these tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
76
0
9

Year Published

2006
2006
2020
2020

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 120 publications
(87 citation statements)
references
References 168 publications
(154 reference statements)
2
76
0
9
Order By: Relevance
“…These findings are consistent with what has been reported worldwide (Fletcher et al, 2002a;Clark et al, 2005;Mankin and Hornicek, 2005). Interestingly, some of the sarcomas in the included studies were documented to have known or suspected causes, such as post-irradiated sinonasal pleomorphic sarcoma situated within the radiation field for previous nasopharyngeal carcinoma (Wang et al, 2009).…”
Section: Discussionsupporting
confidence: 89%
“…These findings are consistent with what has been reported worldwide (Fletcher et al, 2002a;Clark et al, 2005;Mankin and Hornicek, 2005). Interestingly, some of the sarcomas in the included studies were documented to have known or suspected causes, such as post-irradiated sinonasal pleomorphic sarcoma situated within the radiation field for previous nasopharyngeal carcinoma (Wang et al, 2009).…”
Section: Discussionsupporting
confidence: 89%
“…Synovial sarcoma is a malignant tumor that accounts for 10% of all soft-tissue tumors (1). In total, <3 cases per million individuals are diagnosed each year.…”
Section: Introductionmentioning
confidence: 99%
“…Cisplatin and doxorubicinbased chemotherapy are needed in patients with metastatic disease and with a tumour size more than 5 cms. [13] CCS patients have a variable and unpredictable clinical course. A tumour size of >5 cm is an independent prognostic factor and is associated with a poor survival and high incidence of distant metastasis.…”
Section: Discussionmentioning
confidence: 99%